Aminoacidopathy
Gene: BCAT2EnsemblGeneIds (GRCh38): ENSG00000105552
EnsemblGeneIds (GRCh37): ENSG00000105552
OMIM: 113530, Gene2Phenotype
BCAT2 is in 2 panels
1 review
Bryony Thompson (Royal Melbourne Hospital)
6 cases from 5 unrelated families with homozygous or compound heterozygous variant, and supporting functional studies demonstrating decreased BCAT2 enzyme activity for some of the variants. Also, a null mouse model has a phenotype similar to human maple syrup urine disease.
Sources: NHS GMSCreated: 1 Feb 2021, 6:29 a.m. | Last Modified: 1 Feb 2021, 6:37 a.m.
Panel Version: 0.6172
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Hypervalinemia or hyperleucine-isoleucinemia MIM#618850; disorder of branched-chain amino acid metabolism
Publications
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- Expert Review Green
- NHS GMS
- Phenotypes
-
- hypervalinemia and hyperleucine-isoleucinemia MONDO:0100058
- OMIM
- 113530
- Clinvar variants
- Variants in BCAT2
- Penetrance
- None
- Publications
- Panels with this gene
History Filter Activity
Entity classified by Genomics England curator
Bryony Thompson (Royal Melbourne Hospital)Gene: bcat2 has been classified as Green List (High Evidence).
Set publications
Bryony Thompson (Royal Melbourne Hospital)Publications for gene: BCAT2 were set to
Created, Added New Source, Set mode of inheritance, Set Phenotypes
Bryony Thompson (Royal Melbourne Hospital)gene: BCAT2 was added gene: BCAT2 was added to Disorders of branched chain amino acid metabolism. Sources: Expert Review Green Mode of inheritance for gene: BCAT2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: BCAT2 were set to hypervalinemia and hyperleucine-isoleucinemia MONDO:0100058